Articles with "dopamine agonist" as a keyword



Preoperative treatment with dopamine agonist therapy influences surgical outcome in prolactinoma: a retrospective single-center on 159 patients

Sign Up to like & get
recommendations!
Published in 2024 at "Acta Neurochirurgica"

DOI: 10.1007/s00701-024-06198-5

Abstract: Prolactinoma account to the most common pituitary adenomas and current therapy regime constitutes of dopamine agonist therapy (DA) and surgery in selected cases [17]. Due to tumor fibrosis induced by previous DA therapy, surgical removal… read more here.

Keywords: surgical outcome; treatment; therapy; dopamine agonist ... See more keywords

Dopamine agonist for the rapid improvement of visual field defects in giant and macro-prolactinomas.

Sign Up to like & get
recommendations!
Published in 2022 at "Journal francais d'ophtalmologie"

DOI: 10.1016/j.jfo.2022.01.002

Abstract: PURPOSE To evaluate effect of first-line dopamine agonist (DA) therapy as an alternative to surgery for visual field defect (VFD) recovery in giant and macro-prolactinoma. METHODS In this retrospective study, 125 patients with giant and… read more here.

Keywords: dopamine agonist; giant macro; macro prolactinomas; visual field ... See more keywords

Resolution of dopamine agonist-resistant hyperprolactinemia by hysterectomy: a case report

Sign Up to like & get
recommendations!
Published in 2018 at "Gynecological Endocrinology"

DOI: 10.1080/09513590.2017.1379501

Abstract: Abstract Prolactin-producing uterine leiomyomas are very rare. Although hyperprolactinemia rapidly improves after removal of such leiomyomas, no preoperative diagnostic test has been established for prolactin-producing uterine leiomyomas. A 45-year-old Japanese woman, gravida 3 para 3,… read more here.

Keywords: prolactin producing; dopamine agonist; hyperprolactinemia; producing uterine ... See more keywords

Combination of dopamine agonist and prostaglandin administration for pregnancy termination in bitches – a novel approach

Sign Up to like & get
recommendations!
Published in 2020 at "Journal of Applied Animal Research"

DOI: 10.1080/09712119.2020.1814784

Abstract: ABSTRACT Pregnancy termination is a required procedure in companion animal practice. In healthy bitches with confirmed pregnancy, good results are obtained with the combination of prostaglandin F2 and dopamine agonist, followed by regular sonographic examination… read more here.

Keywords: combination; pregnancy; pregnancy termination; dopamine agonist ... See more keywords

Macroprolactinoma-Induced Syndrome of Inappropriate Antidiuresis and Its Reversal with Dopamine Agonist Therapy.

Sign Up to like & get
recommendations!
Published in 2022 at "Laboratory medicine"

DOI: 10.1093/labmed/lmac025

Abstract: Hyponatremia is an uncommon manifestation of pituitary adenomas. Herein, I report a case of syndrome of inappropriate antidiuresis (SIAD) caused by a macroprolactinoma that rapidly resolved with dopamine agonist therapy. A 29-year-old White woman presented… read more here.

Keywords: syndrome inappropriate; agonist therapy; dopamine agonist; macroprolactinoma ... See more keywords

Withdrawal of dopamine agonist treatment in patients with hyperprolactinaemia: A systematic review and meta‐analysis

Sign Up to like & get
recommendations!
Published in 2022 at "Clinical Endocrinology"

DOI: 10.1111/cen.14714

Abstract: To estimate the proportion of patients with persistent normoprolactinaemia following dopamine agonist (DA) withdrawal and to identify predictors of successful withdrawal in patients with hyperprolactinaemia. read more here.

Keywords: treatment patients; withdrawal; dopamine agonist; agonist treatment ... See more keywords

Sex‐based disparities in dopamine agonist response in patients with restless legs syndrome

Sign Up to like & get
recommendations!
Published in 2024 at "Journal of Sleep Research"

DOI: 10.1111/jsr.14311

Abstract: This study aimed to investigate sex‐related differences in the response to ropinirole and pramipexole in patients with restless legs syndrome (RLS). By analysing clinical parameters and polysomnographic (PSG) findings, we sought to elucidate the potential… read more here.

Keywords: dopamine agonist; response; sex; legs syndrome ... See more keywords
Photo from wikipedia

Time until Need for Levodopa among New Users of Dopamine Agonists or MAO-B Inhibitors

Sign Up to like & get
recommendations!
Published in 2021 at "Parkinson's Disease"

DOI: 10.1155/2021/9952743

Abstract: Objective To investigate the use of dopamine agonists and monoamine oxidase type B (MAO-B) inhibitors in the Norwegian population, between 1 July 2006 and 31 December 2016. Our primary endpoint was time until need for… read more here.

Keywords: mao inhibitor; dopamine agonists; mao inhibitors; dopamine agonist ... See more keywords

Cariprazine: A new partial dopamine agonist with a familiar profile

Sign Up to like & get
recommendations!
Published in 2022 at "Australasian Psychiatry"

DOI: 10.1177/10398562211064254

Abstract: Objective Cariprazine is the third partial dopamine agonist now available in Australia. This paper will review the properties, evidence and likely clinical place of cariprazine. Conclusion Cariprazine is a partial agonist with high affinity at… read more here.

Keywords: dopamine; cariprazine; partial dopamine; dopamine agonist ... See more keywords

Status epilepticus induced by treatment with dopamine agonist therapy for giant prolactinoma: a case report

Sign Up to like & get
recommendations!
Published in 2019 at "Journal of Medical Case Reports"

DOI: 10.1186/s13256-018-1939-x

Abstract: BackgroundDopamine agonists are the standard first-line medical therapy for prolactinoma. We report a rare case of giant prolactinoma with a first epileptic seizure due to rapid reduction of the tumor as a complication of dopamine… read more here.

Keywords: agonist therapy; case; prolactinoma; therapy ... See more keywords

Psychological effects of dopamine agonist treatment in patients with hyperprolactinemia and prolactin-secreting adenomas.

Sign Up to like & get
recommendations!
Published in 2019 at "European journal of endocrinology"

DOI: 10.1530/eje-18-0682

Abstract: Background Dopamine agonists (DAs) are the main treatment for patients with hyperprolactinemia and prolactinomas. Recently, an increasing number of reports emphasized DAs' psychological side effects, either de novo or as exacerbations of prior psychiatric disease.… read more here.

Keywords: psychological effects; effects dopamine; patients hyperprolactinemia; dopamine agonist ... See more keywords